• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

藏医药抗击新冠疫情:基础理论与治疗药物

Traditional Tibetan medicine to fight against COVID-19: Basic theory and therapeutic drugs.

作者信息

Zhang Kun, Wang Lijie, Peng Jiayan, Sangji Kangzhuo, Luo Yuting, Zeng Yujiao, Zeweng Yongzhong, Fan Gang

机构信息

State Key Laboratory of Southwestern Chinese Medicine Resources, School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Front Pharmacol. 2023 Feb 16;14:1098253. doi: 10.3389/fphar.2023.1098253. eCollection 2023.

DOI:10.3389/fphar.2023.1098253
PMID:36874035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9978713/
Abstract

The Coronavirus Diseases 2019 (COVID-19) has been rapidly spreading globally and has caused severe harm to the health of people and a substantial social burden. In response to this situation, experts around the world have considered various treatments, including the use of traditional medicine. Traditional Tibetan medicine (TTM), one of the traditional medicines in China, has played an important role in the treatment of infectious diseases in history. It has formed a solid theoretical foundation and accumulated rich experience in the treatment of infectious diseases. In this review, we provide a comprehensive introduction to the basic theory, treatment strategies, and commonly used drugs of TTM for the treatment of COVID-19. In addition, the efficacies and potential mechanisms of these TTM drugs against COVID-19 are discussed based on available experimental data. This review may provide important information for the basic research, clinical application and drug development of traditional medicines for the treatment of COVID-19 or other infectious diseases. More pharmacological studies are needed to reveal the therapeutic mechanisms and active ingredients of TTM drugs in the treatment of COVID-19.

摘要

2019年冠状病毒病(COVID-19)已在全球迅速传播,对人们的健康造成了严重危害,并带来了沉重的社会负担。针对这一情况,世界各地的专家考虑了各种治疗方法,包括使用传统医学。藏医药作为中国传统医学之一,在历史上的传染病治疗中发挥了重要作用。它在传染病治疗方面形成了坚实的理论基础,并积累了丰富的经验。在本综述中,我们全面介绍了藏医药治疗COVID-19的基本理论、治疗策略和常用药物。此外,还根据现有实验数据讨论了这些藏医药药物抗COVID-19的疗效和潜在机制。本综述可能为治疗COVID-19或其他传染病的传统药物的基础研究、临床应用和药物开发提供重要信息。需要更多的药理学研究来揭示藏医药药物治疗COVID-19的治疗机制和活性成分。

相似文献

1
Traditional Tibetan medicine to fight against COVID-19: Basic theory and therapeutic drugs.藏医药抗击新冠疫情:基础理论与治疗药物
Front Pharmacol. 2023 Feb 16;14:1098253. doi: 10.3389/fphar.2023.1098253. eCollection 2023.
2
Traditional Tibetan medicine in China: an overview of current status and prospects.中国传统藏医药:现状与前景概述
Chin J Integr Med. 2015 Jan;21(1):67-70. doi: 10.1007/s11655-014-1893-4. Epub 2014 Dec 24.
3
[Study on methodology for evaluating clinical efficacy of traditional Tibetan medicine].[藏药临床疗效评价方法学研究]
Zhongguo Zhong Yao Za Zhi. 2015 Jan;40(1):160-3.
4
[Analysis of property and efficacy of traditional Chinese medicine in staging revention and treatment of coronavirus disease 2019].[中医药在新型冠状病毒肺炎分期防治中的特性与疗效分析]
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1253-1258. doi: 10.19540/j.cnki.cjcmm.20200225.501.
5
[Usage of ethnomedicine on COVID-19 in China].[中国民族医学在新型冠状病毒肺炎中的应用]
Zhongguo Zhong Yao Za Zhi. 2020 May;45(10):2265-2274. doi: 10.19540/j.cnki.cjcmm.20200316.408.
6
[Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].基于临床经验和分子对接快速建立中医药防治新型冠状病毒肺炎方案
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1213-1218. doi: 10.19540/j.cnki.cjcmm.20200206.501.
7
[Analysis of medication regularity and pharmacodynamic characteristics of traditional Chinese medicine treatment in 444 severe cases of COVID-19].444例新冠肺炎重症病例中医治疗用药规律及药效学特征分析
Zhongguo Zhong Yao Za Zhi. 2020 Jul;45(13):3007-3012. doi: 10.19540/j.cnki.cjcmm.20200427.501.
8
International policies and challenges on the legalization of traditional medicine/herbal medicines in the fight against COVID-19.国际政策与传统医学/草药在抗击 COVID-19 中合法化的挑战
Pharmacol Res. 2021 Apr;166:105472. doi: 10.1016/j.phrs.2021.105472. Epub 2021 Feb 14.
9
Traditional, complementary, and alternative medicine: Focusing on research into traditional Tibetan medicine in China.传统医学、补充医学和替代医学:聚焦于中国藏医药学研究
Biosci Trends. 2016 Jul 19;10(3):163-70. doi: 10.5582/bst.2016.01105. Epub 2016 Jun 13.
10
Natural Medicines Used in the Traditional Tibetan Medical System for the Treatment of Liver Diseases.藏医传统医学体系中用于治疗肝脏疾病的天然药物。
Front Pharmacol. 2018 Jan 30;9:29. doi: 10.3389/fphar.2018.00029. eCollection 2018.

引用本文的文献

1
Recent advancements in traditional Chinese medicine for COVID-19 with comorbidities across various systems: a scoping review.中医药治疗合并多系统疾病的新型冠状病毒肺炎的研究进展:一项范围综述
Infect Dis Poverty. 2024 Dec 19;13(1):97. doi: 10.1186/s40249-024-01263-8.
2
Traditional Tibetan medicine: therapeutic potential in lung diseases.传统藏医学:在肺部疾病中的治疗潜力。
Front Pharmacol. 2024 Mar 18;15:1365911. doi: 10.3389/fphar.2024.1365911. eCollection 2024.
3
The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19.

本文引用的文献

1
Oral GS-441524 derivatives: Next-generation inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase.口服 GS-441524 衍生物:新一代 SARS-CoV-2 依赖 RNA 的 RNA 聚合酶抑制剂。
Front Immunol. 2022 Dec 6;13:1015355. doi: 10.3389/fimmu.2022.1015355. eCollection 2022.
2
Active Ingredients of Reduning Injection Maintain High Potency against SARS-CoV-2 Variants.热毒宁注射液的有效成分对 SARS-CoV-2 变异株仍保持高活性。
Chin J Integr Med. 2023 Mar;29(3):205-212. doi: 10.1007/s11655-022-3686-5. Epub 2022 Nov 14.
3
Bioactive natural products in COVID-19 therapy.
千金藤素的简要概述、抗病毒及抗新型冠状病毒2活性、定量方法和药代动力学:一种潜在的抗2019冠状病毒病小分子药物
Front Pharmacol. 2023 Jul 31;14:1098972. doi: 10.3389/fphar.2023.1098972. eCollection 2023.
用于新冠治疗的生物活性天然产物。
Front Pharmacol. 2022 Aug 19;13:926507. doi: 10.3389/fphar.2022.926507. eCollection 2022.
4
Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue.新型冠状病毒感染的急性后遗症:一个被忽视的公共卫生问题。
Front Public Health. 2022 Jun 17;10:908757. doi: 10.3389/fpubh.2022.908757. eCollection 2022.
5
Traditional uses, phytochemistry, pharmacology, and toxicology of (C. B. Clarke) Höeck: a review.(C. B. 克拉克)赫克的传统用途、植物化学、药理学及毒理学综述
RSC Adv. 2021 Aug 26;11(46):28761-28774. doi: 10.1039/d1ra05548h. eCollection 2021 Aug 23.
6
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.抗击 SARS-CoV-2 大流行需要采取全球方法来了解疫苗反应的异质性。
Nat Immunol. 2022 Mar;23(3):360-370. doi: 10.1038/s41590-022-01130-4. Epub 2022 Feb 24.
7
A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis.芦丁防治 COVID-19/哮喘合并症的药理学机制探索的实用策略:系统药理学和生物信息学分析的结果。
Front Immunol. 2022 Jan 7;12:769011. doi: 10.3389/fimmu.2021.769011. eCollection 2021.
8
Computational and In Vitro Experimental Investigations Reveal Anti-Viral Activity of Licorice and Glycyrrhizin against Severe Acute Respiratory Syndrome Coronavirus 2.计算和体外实验研究揭示甘草和甘草酸对严重急性呼吸综合征冠状病毒2的抗病毒活性。
Pharmaceuticals (Basel). 2021 Nov 24;14(12):1216. doi: 10.3390/ph14121216.
9
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.莫努匹韦片用于非住院 COVID-19 患者的口服治疗。
N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16.
10
Broad-spectrum prodrugs with anti-SARS-CoV-2 activities: Strategies, benefits, and challenges.具有抗 SARS-CoV-2 活性的广谱前药:策略、益处和挑战。
J Med Virol. 2022 Apr;94(4):1373-1390. doi: 10.1002/jmv.27517. Epub 2021 Dec 18.